Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
Clinical trial NCT02178475 · COMPLETED
Trial details
- NCT number
- NCT02178475
- Sponsor
- Amgen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-07-18
- Primary completion
- 2016-10-28
- Enrollment
- 943
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.